Document Detail


A flow-based synthesis of imatinib: the API of Gleevec.
MedLine Citation:
PMID:  20309467     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A concise, flow-based synthesis of Imatinib, a compound used for the treatment of chronic myeloid leukaemia, is described whereby all steps are conducted in tubular flow coils or cartridges packed with reagents or scavengers to effect clean product formation. An in-line solvent switching procedure was developed enabling the procedure to be performed with limited manual handling of intermediates.
Authors:
Mark D Hopkin; Ian R Baxendale; Steven V Ley
Related Documents :
12010417 - Evolving perspectives in product safety for haemophilia.
15120427 - Material and heavy metal balance in a recycling facility for home electrical appliances.
14765507 - Blood or blood products: minister's decision to deny application to extraordinary assis...
11776287 - Oxygen carriers ("blood substitutes").
7243397 - Relation between blood resistivity and hematocrit in fresh human fetal blood.
2656807 - Exacerbation of psoriasis during lithium treatment.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-05
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  46     ISSN:  1364-548X     ISO Abbreviation:  Chem. Commun. (Camb.)     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-23     Completed Date:  2010-07-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  England    
Other Details:
Languages:  eng     Pagination:  2450-2     Citation Subset:  IM    
Affiliation:
Innovative Technology Centre, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / chemical synthesis*,  chemistry,  therapeutic use
Dimethylamines / chemistry
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Piperazines / chemical synthesis*,  chemistry,  therapeutic use
Pyrimidines / chemical synthesis*,  chemistry,  therapeutic use
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Dimethylamines; 0/Piperazines; 0/Pyrimidines; 110-85-0/piperazine; 124-40-3/dimethylamine; 152459-95-5/imatinib

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Organocatalytic asymmetric synthesis of polyfunctionalized 3-(cyclohexenylmethyl)-indoles via a quad...
Next Document:  Organometallic control at the nanoscale: a new, one-pot method to decorate a magnetic nanoparticle s...